Browsing Category
Croda
Unveiling the Potential of Nanosuspension Formulation Strategy for Improved Oral Bioavailability of…
Abstract
Gefitinib (GB), an oral tyrosine kinase inhibitor suffers major setbacks in clinical application due to limited aqueous solubility leading to poor oral bioavailability. Nanosuspension serves as a promising formulation strategy to overcome the above-mentioned drawbacks. Hence, the present…
Read More...
Read More...
Trans-Resveratrol-Loaded Nanostructured Lipid Carrier Formulations for Pulmonary Drug Delivery Using…
Abstract
Aerosolization is a non-invasive approach of delivering drugs for both localized and systemic effects, specifically pulmonary targeting. The aim of this study was to deliver trans-resveratrol (TR) as an anti-cancer drug entrapped in a new generation versatile carriers nanostructured lipid…
Read More...
Read More...
Nanostructured Strategies for Melanoma Treatment—Part II: Targeted Topical Delivery of Curcumin via…
Abstract
Background/Objectives: Curcumin (CUR) is a natural compound with notable antitumor properties but faces limitations in topical applications due to poor aqueous solubility, instability, and insufficient skin penetration. To overcome these challenges, a nanomicellar formulation…
Read More...
Read More...
Investigation of bioavailability and anti-pancreatic cancer efficacy of a self-nanoemulsifying…
Abstract
Aims
A new self-nanoemulsifying drug delivery system (SNEDDS) was developed for erlotinib (Ert) oral delivery.
Highlights
A pseudo-ternary phase diagram for olive oil, Tween 80 and PEG 600 was constructed.
A SNEDDS composed of 10% olive oil, 20% Tween 80 and 70% (V)…
Read More...
Read More...
Bespoke hydroxypropyl methylcellulose-based solid foams loaded with poorly soluble drugs by tunable…
Abstract
A tunable modular design (TMD) as a new approach was proposed to tailor the dose and drug release profile of poorly water-soluble drugs from hydroxypropyl methylcellulose (HPMC)-based solid foams by combining two manufacturing principles:
(1) freeze-drying aqueous HPMC-based gels to…
Read More...
Read More...
Machine learning driven acceleration of biopharmaceutical formulation development using Excipient…
Abstract
Formulation development of protein biopharmaceuticals has become increasingly challenging due to new modalities and higher desired drug substance concentrations. The constraint in drug substance supply and the need for a holistic set of analytical methods means that only a small selection…
Read More...
Read More...
Enhancing the Photothermal Properties of Indocyanine Green in Melanoma Spheroids via Encapsulation…
Abstract
Indocyanine green (ICG), a well-known photosensitiser, has shown potential in photothermal therapy (PTT) for cancer treatment, but its effectiveness is limited by poor skin penetration and rapid clearance. To address this, lipid nanocapsules (LNCs) were used as nanocarriers to enhance…
Read More...
Read More...
Autoclaving behavior of trimyristin nanoemulsions stabilized with different poloxamers
Abstract
Lipid nanoemulsions are being investigated as carrier systems for the parenteral administration of poorly soluble drugs. Defined particle sizes, narrow particle size distributions, and sterility are prerequisites for the safe administration of such formulations to patients. In the current…
Read More...
Read More...
Soluplus®-Based Pharmaceutical Formulations: Recent Advances in Drug Delivery and Biomedical…
Abstract
Poor water solubility remains a significant challenge in the pharmaceutical industry that limits the therapeutic efficacy and bioavailability of many active pharmaceuticals. Soluplus® (SLP), an amphiphilic graft copolymer made of polyethylene glycol, polyvinyl caprolactam, and polyvinyl…
Read More...
Read More...
Praziquantel Nanoparticle Formulation for the Treatment of Schistosomiasis
Abstract
Schistosomiasis, a parasitic disease affecting around 250 million people globally, primarily children, necessitates the urgent development of pediatric praziquantel formulations, as outlined in the WHO neglected tropical diseases roadmap 2021–2030. We developed a low-cost PZQ…
Read More...
Read More...